Bruserud, Øystein <br/><br/>
Subclassification of patients with acute myelogenous leukemia based on chemokine responsiveness and constitutive chemokine release by their leukemic cells.  [electronic resource] 

 -  Haematologica  Mar 2007 
 - 332-41 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1592-8721 
<br/><br/><label>Standard No.: </label>10.3324/haematol.10148  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Boronic Acids--pharmacology<br/>Bortezomib<br/>Cell Division--drug effects<br/>Cell Line, Tumor--drug effects<br/>Chemokines--metabolism<br/>Chemotaxis--drug effects<br/>DNA Replication--drug effects<br/>Female<br/>Hematopoietic Cell Growth Factors--pharmacology<br/>Humans<br/>Leukemia, Myeloid--classification<br/>Male<br/>Middle Aged<br/>NF-kappa B--biosynthesis<br/>Neoplasm Proteins--biosynthesis<br/>Pyrazines--pharmacology<br/>Receptors, Chemokine--biosynthesis<br/>Recombinant Fusion Proteins--pharmacology<br/>T-Lymphocytes--drug effects<br/>Tumor Stem Cell Assay